U.S. Physical Therapy, Inc. (NYSE:USPH – Get Free Report) Director Peter Francis Minan acquired 492 shares of U.S. Physical Therapy stock in a transaction that occurred on Monday, June 8th. The shares were purchased at an average price of $63.14 per share, with a total value of $31,064.88. Following the purchase, the director owned 2,923 shares in the company, valued at $184,558.22. This represents a 20.24% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Peter Francis Minan also recently made the following trade(s):
- On Tuesday, June 9th, Peter Francis Minan acquired 288 shares of U.S. Physical Therapy stock. The shares were purchased at an average price of $61.50 per share, with a total value of $17,712.00.
U.S. Physical Therapy Stock Up 1.8%
Shares of NYSE USPH traded up $1.12 during trading hours on Wednesday, hitting $62.92. 222,611 shares of the stock were exchanged, compared to its average volume of 207,326. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.41. U.S. Physical Therapy, Inc. has a 12 month low of $58.19 and a 12 month high of $93.50. The company has a market cap of $957.63 million, a PE ratio of 125.84, a PEG ratio of 1.69 and a beta of 1.16. The firm has a fifty day moving average price of $68.81 and a 200-day moving average price of $76.42.
U.S. Physical Therapy Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, June 12th. Shareholders of record on Friday, May 22nd will be paid a dividend of $0.46 per share. The ex-dividend date is Friday, May 22nd. This represents a $1.84 dividend on an annualized basis and a yield of 2.9%. U.S. Physical Therapy’s dividend payout ratio is presently 368.00%.
Wall Street Analyst Weigh In
A number of research analysts have issued reports on the stock. Zacks Research upgraded shares of U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a research note on Wednesday, May 27th. Jefferies Financial Group upgraded shares of U.S. Physical Therapy to a “strong-buy” rating in a research note on Thursday, March 12th. Barrington Research cut their price target on shares of U.S. Physical Therapy from $103.00 to $90.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 13th. Weiss Ratings restated a “hold (c-)” rating on shares of U.S. Physical Therapy in a research note on Friday, May 29th. Finally, Citizens Jmp cut their price target on shares of U.S. Physical Therapy from $113.00 to $98.00 and set a “market outperform” rating on the stock in a research note on Friday, May 8th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $97.50.
Read Our Latest Research Report on USPH
Institutional Trading of U.S. Physical Therapy
A number of hedge funds and other institutional investors have recently made changes to their positions in USPH. William Blair Investment Management LLC acquired a new stake in shares of U.S. Physical Therapy in the third quarter worth $29,381,000. American Century Companies Inc. acquired a new stake in shares of U.S. Physical Therapy in the third quarter worth $21,940,000. Bahl & Gaynor Inc. increased its stake in shares of U.S. Physical Therapy by 47.6% in the third quarter. Bahl & Gaynor Inc. now owns 474,688 shares of the company’s stock worth $40,325,000 after acquiring an additional 153,054 shares during the period. Bank of America Corp DE increased its stake in shares of U.S. Physical Therapy by 77.2% in the third quarter. Bank of America Corp DE now owns 317,200 shares of the company’s stock worth $26,946,000 after acquiring an additional 138,194 shares during the period. Finally, Schroder Investment Management Group increased its stake in shares of U.S. Physical Therapy by 45.9% in the fourth quarter. Schroder Investment Management Group now owns 364,253 shares of the company’s stock worth $29,603,000 after acquiring an additional 114,618 shares during the period.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.
In addition to traditional rehabilitation services, U.S.
See Also
- Five stocks we like better than U.S. Physical Therapy
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
- This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
- Intel Is the Market’s Most Mispriced AI Hedge
- The Biggest Opportunity From SpaceX’s IPO May Surprise You
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.
